We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
G-SARTAN HCT, TELMISARTAN HCTZ JL, TELMISARTAN HCTZ GXP, ATX TELMISARTAN HCT, TELMISARTAN HCTZ RY, TELMISARTAN HCTZ GPPL (Generic Partners Pty Ltd)
Product name
G-SARTAN HCT, TELMISARTAN HCTZ JL, TELMISARTAN HCTZ GXP, ATX TELMISARTAN HCT, TELMISARTAN HCTZ RY, TELMISARTAN HCTZ GPPL
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
187 working days (255)
Active ingredients
telmisartan; hydrochlorothiazide
Registration type
New generic medicine
Indication
Telmisartan and hydrochlorothiazide (tablets) are indicated for the treatment of hypertension. Treatment should not be initiated with these combinations.